• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: JOHNSON & JOHNSON VISION CARE, INC. - US ACUVUE® OASYS®; LENSES, SOFT CONTACT, EXTENDED WEAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

JOHNSON & JOHNSON VISION CARE, INC. - US ACUVUE® OASYS®; LENSES, SOFT CONTACT, EXTENDED WEAR Back to Search Results
Catalog Number PH
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Blurred Vision (2137); Eye Infections (4466); Eye Pain (4467)
Event Date 10/01/2023
Event Type  Injury  
Manufacturer Narrative
H3 other text : suspect product not returned.
 
Event Description
On (b)(6) 2023, an email was received from a patient (pt) in argentina reporting a diagnosis of entamoeba in the left eye (os) while wearing an acuvue® oasys® brand contact lens (cl).The pt reported ¿entamoeba is directly related to contact lenses¿ and i currently ¿have a major injury and am in treatment¿ (details of treatment not provided).The pt is reporting a purchase of 6 cl boxes and is ¿afraid they¿re infected.¿ no additional information is provided.On 23oct2023, the pt called to provide additional information.The pt experienced discomfort in the os last week, ¿like pitching sensation¿ after 2 days of use.The pt experienced pain on the 3rd day of use in the morning and could not open the eye.The pt used an eye drop (name not provided).The pt visited an eye care professional (ecp) (date not provided), and advised the medication the pt took did not resolve the issue.The ecp recommended the pt visit a specialist.The pt visited a 2nd ecp at an urgent care and the ecp ¿did a scraping procedure¿ on the pt¿s cornea.The ecp diagnosed entamoeba ¿90% related to use cls.¿ the pt will be in treatment for 2 to 6 months.The ecp prescribed clorexidina, 1 drop every hour, ¿then now one drop each 2 hours.¿ the ecp also prescribed gatfloxacina, 0.5%, four times daily and ¿phom" medication (the pt is awaiting on the delivery of the medication).The pt reported the os vision has not completely recovered.Additional attempts via email and phone were made to obtain additional medical information from the pt on 25oct2023, 30oct2023, 06nov2023 and 13nov2023, with no success.The date of the event will be documented as (b)(6) 2023 as the actual date of the event is unknown.This os event is being reported as a worst-case event as we were unable to verify the pt's diagnosis and treatment with the treating ecp.No additional medical information has been received.A lot history review was performed and revealed the following: the batch records did not show any abnormalities in monomer and solution testing.All parameters tested were within specification.All sterilization requirements were successfully completed.Lot number b012cm3 was produced under normal conditions.The suspect product has not been received for evaluation.No additional evaluation can be conducted.If any further relevant information is received, a supplemental report will be filed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ACUVUE® OASYS®
Type of Device
LENSES, SOFT CONTACT, EXTENDED WEAR
Manufacturer (Section D)
JOHNSON & JOHNSON VISION CARE, INC. - US
7500 centurion parkway
jacksonville FL 32256
Manufacturer Contact
helene aguilar
7500 centurion parkway
jacksonville, FL 32256
9047429918
MDR Report Key18139529
MDR Text Key328156473
Report Number1057985-2023-00085
Device Sequence Number1
Product Code LPM
Combination Product (y/n)N
Reporter Country CodeAR
PMA/PMN Number
P040045
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Consumer
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 11/15/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Catalogue NumberPH
Device Lot NumberB012CM3
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 10/23/2023
Initial Date FDA Received11/15/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured08/10/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
Patient SexFemale
-
-